2025 Annual Meeting | C165 - Spanish: Dolor de cabeza (Headache)

Date Tuesday 04/08/25

Time 03:30 PM - 05:30 PM PDT Add To Calendar

Location San Diego Convention Center | 24C

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Gloria P. Simms, MD, FAAN

Topic(s) Headache

Learning Objectives Participants should get a review of migraine physiopathology with a focus on targets for new treatment options, and a comprehensive review of the state-of-the-art of use of CGRP blockers in acute and prophylactic migraine based on real-world evidence.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement

Program Level Intermediate

Program Tracks Spanish Language

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Other

Program Materials Program Evaluations

Event Timeline
03:30 PM - 03:35 PM PDT	Introduction	Introducción al Programa de Cefalea en Español Gloria P. Simms, MD, FAAN
03:35 PM - 03:55 PM PDT	Speaker	Fisiopatología de la Migraña: Nuevos Blancos para Tratamiento Michel Volcy
03:55 PM - 04:35 PM PDT	Speaker	Anti-CGRP en el tratamiento agudo de migraña: evidencia del mundo real Carolina Guerra Posada
04:35 PM - 05:15 PM PDT	Speaker	Anti-CGRP tratamiento preventivo de migraña: evidencia y experiencia en el mundo real Gloria P. Simms, MD, FAAN
05:15 PM - 05:30 PM PDT	Q&A	Questions and Answers Gloria P. Simms, MD, FAAN, Michel Volcy, Carolina Guerra Posada

Faculty Disclosures
Gloria P. Simms, MD, FAAN	Dr. Simms has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Simms has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie .
Michel Volcy	Michel Volcy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for PFIZER. Michel Volcy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ABBVIE. Michel Volcy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LILLY. Michel Volcy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ABBOTT. Michel Volcy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PFIZER. Michel Volcy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBVIE. Michel Volcy has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for LILLY. Michel Volcy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Michel Volcy has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ASOLACE. Michel Volcy has received personal compensation in the range of $10,000-$49,999 for serving as a NEUROLOGY PROFESSOR with UNIVERSIDAD DE ANTIOQUIA.
Carolina Guerra Posada	Carolina Guerra Posada has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Asociación latinoamericana de cefaleas.

��ɫ��

��ɫ��